[ Price : $8.95]
FDA approves Regeneron Pharmaceuticals PD-1 inhibitor Libtayo (cemiplimab-rwlc) in combination with platinum-based chemotherapy fo...[ Price : $8.95]
Office of Combination Products director Thinh Nguyen says seven draft and final guidances affecting combination products should be...[ Price : $8.95]
Federal Register notice: FDA makes available a final guidance entitled Studying Multiple Versions of a Cellular or Gene Therapy Pr...[ Price : $8.95]
Federal Register notice: FDA posts a final guidance entitled M10 Bioanalytical Method Validation and Study Sample Analysis.[ Price : $8.95]
A Phase 3 trial of GSKs accelerated-approved Blenrep (belantamab mafodotin) in patients with relapsed or refractory multiple myelo...[ Price : $8.95]
FDA slaps a clinical hold on a Verve Therapeutics IND for its VERVE-101 in patients with heterozygous familial hypercholesterolemi...[ Price : $8.95]
Verrica Pharmaceuticals says it is filing an NDA resubmission in the first quarter next year for VP-102 to treat molluscum contagi...